17 Sep 2008 | 11:11
Aurobindo Pharma receives USFDA approval
Aurobindo Pharma is pleased to announce that it has received the
tentative approval to manufacture and market Abacavir Sulfate tablets
60mg from USFDA.
Aurobindo Pharma receives USFDA approval
Aurobindo Pharma is pleased to announce that it has received the
tentative approval to manufacture and market Abacavir Sulfate tablets
60mg from USFDA.
The
new drug application 22-293 provides for the use of Abacavir Sulfate
60mg tablets in combination with other antiretrovirals for use in
pediatric patients for the treatment of HIV-1 infection.
The
company had earlier received tentative approvals to Abacavir Sulfate
tablets 300mg and Abacavir Sulfate oral solution 20mg/ml. This is
Aurobindo's 77th ANDA approval from USFDA.
The company made this announcement during the trading hours today, 17 September 2008.
0 comments:
Post a Comment